GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035 | Industry: Pharmaceuticals
| Mid-range Performer

1980.2000 21.00 (1.07%)

NSE Oct 03, 2025 15:31 PM

55.25% Gain from 52W Low

Volume: 419.7K

Glenmark Pharmaceuticals Ltd.

10 Feb 2025

1980.20

1.07%

Company Update

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Cosmo and Glenmark Announce UK MHRA Approval of Winlevi for Treatment of Acne

More from Glenmark Pharmaceuticals Ltd.

Recommended

Five Interesting Stocks Today - October 3, 2025

The Baseline | 03 Oct 2025, 04:45PM

Market closes higher, PTC Industries’ arm wins contract to supply RDH parts to Coolbrook

Trendlyne Marketwatch | 03 Oct 2025, 04:04PM

Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals